|
Vectura rises after swinging to first-half profit
The Guardian (blog) Vectura, which specialises in drugs for respiratory diseases such as asthma and chronic obstructive pulmonary (COPD) disease, enjoyed a 5% bounce in its share price after swinging to a first-half profit. The shares climbed 3.25p to 68.7p. … VECTURA GROUP PLC : Half Yearly Report |
View full post on asthma – Google News